Wang, Ning
Mo, Zhenxian
Pan, Lu
Zhou, Minhua
Ye, Xiaolan
Liu, Xinjian
Cai, Xiong
Qian, Changgeng
Chen, Feili
Xiong, Yan
Fan, Fushun
Li, Wenyu https://orcid.org/0000-0002-6444-7149
Funding for this research was provided by:
National Science and Technology Major Project (2016ZX09101002)
Guangdong Provincial Pearl River Talents Program (2014ZT05Y232)
Guangzhou Municipal Science and Technology Project (201909020004)
Article History
Accepted: 2 October 2023
First Online: 19 October 2023
Declarations
:
: This study is funded by National Science and Technology Major Project of China (2016ZX09101002), Guangdong Pearl River Talents Plan (2014ZT05Y232), Guangzhou Municipal Science and Technology Project (201909020004).
: C. Qian and X. Cai are inventors of BEBT-908 and founders of Guangzhou BeBetter Medicine Technology Co., Ltd. N.Wang, Z.Mo, L.Pan, M.Zhou, X.Ye, X.Liu, F.Chen, Y. Xiong, F.Fan, W.Li declare that they have no conflicts of interest that might be relevant to the contents of this article.
: The animal study was approved by Curis Inc and Ruiye Animal Model Inc Animal Use and Care Committee.
: Not applicable due to the study being preclinical in nature.
: The data generated in the present study are included in the article and the .
: Not applicable.
: Conceptualization: WL, FF, XL, CQ; Methodology: NW, ZM, LP, MZ, XY, FC; Validation: WL, FF, NW; Formal Analysis: FF, NW; Investigation: WL, FF; Resources: WL, CQ, XC, YX; Data curation: FF, NW; Writing—original draft preparation: NW, FF; Writing—review and editing: FF, XL; Supervision: FF, XL; Project administration: WL, FF; Funding acquisition: CQ.